Riedel Norbert G

SEC CIK: 0001161662

SEC filings (opens in a new tab)

In the past year, 1 open-market sale filing worth $655.7K and no purchases.

Current role at each company

JAZZ Jazz Pharmaceuticals plcDirectoras of Sep 2, 2026
ETON Eton Pharmaceuticals, Inc.Directoras of Aug 4, 2026
CERE Cerevel Therapeutics Holdings, Inc.Directoras of Aug 5, 2024
APTX Aptinyx Inc.EXECUTIVE CHAIRMAN OF THE BODas of Jan 5, 2023

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $655.7K; 1 filing
Net: −$655.7K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Riedel Norbert G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

JAZZ Jazz Pharmaceuticals plc

Director4 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Mar 2, 2026 (view filing)	Feb 27	3 days	Riedel Norbert GDirector	SSale	−3.42K	$192.00	−$655.7K	−32.7%7.02K after
Aug 15, 2023 (view filing)	Aug 14	1 day	Riedel Norbert GDirector	SSale	−1.24K	$138.16	−$171.5K	−8.3%13.7K after
Aug 9, 2022 (view filing)	Aug 5-8	4 days	Riedel Norbert GDirector	SSale	−9.09K	$155.44	−$1.41M	−43.4%11.9K after	2 lots
Aug 10, 2021 (view filing)	Aug 6	4 days	Riedel Norbert GDirector	SSale	−1.31K	$147.96	−$193.2K	−11.2%10.4K after

APTX Aptinyx Inc.

EXECUTIVE CHAIRMAN OF THE BOD1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Dec 8, 2021 (view filing)	Dec 6	2 days	Riedel Norbert GCEO	PPurchase	+100.0K	$2.23	+$223.0K	New position100.0K after